Evaluation and Comparison of Keloids and Second Degree Burns Blisters Fluid
Comparison of the Blister Fluid Components of Second Degree Burned Patients With the Blister Fluid Components Following Intralesional Cryosurgery of Keloid Scars - A Feasibility Study.
1 other identifier
observational
20
1 country
1
Brief Summary
It is well documented that following thermal burns injury the development of hypertrophic scars and keloid (HSK) ranges between 40 to 90%. on the other hand It is well documented that cryosurgery wounds generally heal with minimal tissue contraction, resulting in good cosmetic results and with minimal complications. The Aim of the study is To specify the burn and cryosurgery blister fluid for proteins, cytokines and cells and To compare between the above data regarding possible proteins, cytokines and cells, in regard to their possible effect on scarring and wound healing. Also to Identify those components which are present only in the cryosurgery blister and which might have an anti-scarring effect and to characterize them biochemically.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jul 2012
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 22, 2012
CompletedFirst Posted
Study publicly available on registry
June 26, 2012
CompletedStudy Start
First participant enrolled
July 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2018
CompletedFebruary 16, 2017
February 1, 2017
5.9 years
June 22, 2012
February 15, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
comparison of inflamation cells and proteins (proteomic evaluation) between blisters caused by heat and blisters caused by cryo injury
the protein evaluation and comparison is achieved by the use of proteomic study which evaluate the quantity of about 700 different proteins in the fluid of the different blisters (heat blisters compared to "cryo" blisters). we also evaluate the differences in quntities between the inflamation cells in each sample.
at time of sampling.
Study Arms (2)
second degree blisters patients
blister fluids of second degree burns
cryotherapy blisters
blister fluids of cryosurgery wounds
Eligibility Criteria
patients with second degree burns patients status post cryosurgery treatment for keloid scars with post treatment blisters
You may qualify if:
- subject agrees to enroll in the research
- subject provides written authorization for use and disclosure of protected health information
- subject provides written informed consent
- subject who suffer a second degree burn with intact blisters from hot water or liquid within 24 hours, and have been admitted to the emergency room at Carmel Medical center
- subject suffering from keloids and are treated at the Department of Plastic Surgery , Linn Medical Center, by the intralesional cryosurgery method within the last 24 hours and have developed an intact blister
You may not qualify if:
- subject who has a blister exudate that is culture positive
- subject who has any signs of infection in and/or around the blister
- subject with blisters present more then 24 hours (after which samples will not be taken)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Carmel Medical Center
Haifa, Haifa District, Israel
Biospecimen
blister fluid of kryosurgery and second degree burns Following the results of the above study a further extension of the study is progressing in which the identification of the cell population in the blister fluid following intralesional cryosurgery of keloid scars is examined
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
yaron har-shai, Md
carmel medical center- ISRAEL
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
June 22, 2012
First Posted
June 26, 2012
Study Start
July 1, 2012
Primary Completion
June 1, 2018
Study Completion
July 1, 2018
Last Updated
February 16, 2017
Record last verified: 2017-02